补肾通阳化瘀法治疗稳定型心绞痛的临床研究
|
摘要
目的:观察温阳化瘀汤治疗稳定型心绞痛肾虚痰瘀阻滞证的临床疗效,并探讨其作用机制。方法:随机选择冠心病稳定型劳累性心绞痛Ⅰ～Ⅲ级的患者60例,每组30例。分为治疗组(30例)和对照组(30例)。分别予以补肾通阳化瘀法和养心氏片对照治疗,一个月后观察疗效。结果:稳定型心绞痛总有效率,治疗组为90.0%、对照组为76.7%,治疗组优于对照组(P<0.05);中医证候疗效,治疗组总有效率为93.3%、对照组为70.0%,治疗组优于对照组(P<0.05);心电图疗效,治疗组总有效率为80.0%、对照组总有效率60.0%,治疗组优于对照组(P<0.05)。结论:温阳化瘀汤能明显改善稳定型心绞痛患者的临床症状,提高临床疗效。显著改善血脂代谢紊乱,改善心电图疗效。并在一定程度上促进血栓的溶解,最终达到抗心肌缺血、缺氧,保护心室功能,防止心绞痛发作,本研究结果为稳定型心绞痛的防治提供了新的思路和方法。
Purpose:Observe the Yu soup of anodizing to cure to stabilize a type an angina pectoris kidney falsely the phlegm Yu block Zhi the clinical curative effect of the certificate, and inquire into it acting a machining.Method:Random select coronary stabilization type tired sex angina pectorisⅠ~the sufferer ofⅢclass is 60, each 30.Is divided into treatment set(is 30) and matched control.(is 30)Restore virility an anodizing Yu law and cultivate mental calm a surname slab respectively collate to cure and observe curative effect after a month.Result:Stable type the angina pectoris is always efficient, the treatment set is a 90.0%, matched control is 76.7%, treatment set better than matched control;(P<0.05)The Chinese medicine certificate waits curative effect, the treatment set is always efficient for the 93.3%, matched control for 70.0%, treatment set better than matched control;(P<0.05)Electrocardiogram curative effect, the treatment set is always efficient to is always efficient 80.0%, matched control 60.0%, treatment set better than matched control.(P<0.05) Conclusion:The Yu soup of anodizing can obviously improve the clinical symptom of stabilized angina pectoris sufferer and raise clinical curative effect.Show Zhao improvement the blood fat metabolism mess, improve electrocardiogram curative effect.Combine to promote to some extent the dissolution that the blood bolts, finally hit an anti- myocardial to lack blood, anoxia, protect ventricles function, keep angina pectoris from going into action, this search result for stabilized the prevention and cure of type angina pectoris to provide new way of thinking and method.
Purpose:Observe the Yu soup of anodizing to cure to stabilize a type an angina pectoris kidney falsely the phlegm Yu block Zhi the clinical curative effect of the certificate, and inquire into it acting a machining.Method:Random select coronary stabilization type tired sex angina pectorisⅠ~the sufferer ofⅢclass is 60, each 30.Is divided into treatment set(is 30) and matched control.(is 30)Restore virility an anodizing Yu law and cultivate mental calm a surname slab respectively collate to cure and observe curative effect after a month.Result:Stable type the angina pectoris is always efficient, the treatment set is a 90.0%, matched control is 76.7%, treatment set better than matched control;(P<0.05)The Chinese medicine certificate waits curative effect, the treatment set is always efficient for the 93.3%, matched control for 70.0%, treatment set better than matched control;(P<0.05)Electrocardiogram curative effect, the treatment set is always efficient to is always efficient 80.0%, matched control 60.0%, treatment set better than matched control.(P<0.05) Conclusion:The Yu soup of anodizing can obviously improve the clinical symptom of stabilized angina pectoris sufferer and raise clinical curative effect.Show Zhao improvement the blood fat metabolism mess, improve electrocardiogram curative effect.Combine to promote to some extent the dissolution that the blood bolts, finally hit an anti- myocardial to lack blood, anoxia, protect ventricles function, keep angina pectoris from going into action, this search result for stabilized the prevention and cure of type angina pectoris to provide new way of thinking and method.
引文
[1]郑筱萸.中药新药临床研究指导原则.北京:中国医药科技出版社,1993;28. 41-45.
[2]史载祥,等.现代中医心血管病学.北京:人民卫生出版社,2006.845-847.
[3]曹洪欣,张华敏.痰癖互结与冠心病机理辨识田.中医药学刊,2001,19(6): 544-545.
[4]王慧丽.补肾通心汤治疗老年冠心病心绞痛56例[J].吉林中医药,2003,2(5): 15.
[5]樊永平.王绵之教授治疗冠心病的经验.贵阳中医学院学报,1995,17(1):38 39,42.
[6]何应群.力可生颗粒剂治疗心绞痛62例疗效观察[J].国医论坛,2000,15(6), 26.
[7]赵永强.冠心病心绞痛脏腑辨证的临床意义[J] ,中西医结合心脑血管杂志, 2003,1(11):673.
[8]吕健,黄坚明,吴乐文分型治疗冠心病心绞痛190例临床观察四川中医2001 19(7):31-32.
[9]邓宝澄.自拟冠心通汤防治不稳定性心绞痛35例[J]辽宁中医杂志2002,29 (2):90.
[10]郭晓华,王宜芳.补心肾化痰瘀治疗冠心病初探[J].陕西中医,2006,27(11): 1388-1390.
[11]王洛芳.第四军医大学学报,1986;7(2):164.
[12]刘崇铭,于庆海,张利民.淫羊藿甙对心脏的影响[J]中草药,1982.13(9):30
[13]蒋淑君,许兰芝.淫羊藿总黄酮的药理作用研究进展[J].中国药学报,2004, 32(4):60.
[14]王英军,唐炜,孙英莲,等.淫羊藿总苷对麻醉开胸犬血流动力学的影响[J].中药药理与临床,2006,22(3、4):66.
[15]高其铭.西安医科大学学报,1992;13(3):223.
[16]胡娟,叶蕻芝,冯亚,等.3种闽产中药体外对大鼠血小板凝集的影响[J].福建中医学院学报,2007,17(6):23-26.
[17]付润芳,冯国清,于爽,等.复方美沙芬颗粒对枸橼酸引咳豚鼠镇咳及对蟾蜍食管纤毛运动的作用[J] .郑州大学学报(医学版),2007,42 ( 6 ):1159-1161.
[18]张贺鸣,韩联合,冯国清,等.巴戟天对培养乳鼠心肌细胞缺氧复氧损伤的防护作用.河南中医学院学报,2005;20(8):20-21.
[19]郑虎占,董泽宏,余靖.中药现代研究与应用[M],北京:学苑出版社,1998,第1版:2547-4638.
[20]田代华.实用中药辞典[M],北京:人民卫生出版社,2002,第1版:1533-1537.
[21]邹丽琐,等.桂枝蒸馏液对离体灌流鼠心缺血再灌注损伤的保护作用.北京中医药大学学报,1997,20(2):22.
[22]刘晓亮,董均树,杨秋平.复方丹参注射液对冠状动脉粥样硬化性心脏病患者的影响[M].中西医结合实用临床急救, 1998;5(l2):559.
[23]阴健主编.中药现代研究与临床应用[M].第一版.学苑出版社,1993,10.
[24] Liu AH, LinYH, YangM, et al. Developmentof the fingerprints for the quality of the roots of Salviamiltiorrhiza and its related preparations by HPLC-DAD and LC-MSN [J]. Journal of Chromatography, 2007,846:32-41.
[25]吴毓敏,梁振昌,吴虹.水蛭的抗血栓作用观察.山西医学院学报,1995;26(2):89.
[26]洪行球,沃兴德.半夏降血脂作用研究[J].浙江中医学报,1995,19( 2) :28.
[27]陈凌云,杨国祥.半夏药理研究概况.云南中医学院学报,1997;20(4):17-19.
[28]蒋文跃,杨宇.化痰药半夏、瓜蒌、浙贝母、石菖蒲对大鼠血液流变性的影响[J].中医杂志, 2002, 43( 3) : 215.
[29]马清钧,王淑玲.临床实用中药学,南昌:江西科学技术出版社,2001:717.
[30]雷载权主编.中药学,上海:上海科技出版社,1995,第1版:279.
[31] Adamn Alemayehn et al. Britsh journal of pharmalology 1994:111:205.
[32] C.C.Chou et Amrtican journal of phystology 1989:257:G709.
[33]彭洪福等:高原医学杂志,(l):29 .1985.
[34]李红芳,李丹明,瞿颂义,等枳实和陈皮对兔离体主动脉平滑肌条作用机理探讨[J]中成药, 2001,23(9):6581.
[35] Francisco Or allo, Ezequiel lvarez,H l ne Basar an, et all Comparative study of the vasorelaxant activity, super oxide-scavenging ability and cyclic nucleotide phos phodieste rase - inhibitory effects of hesper etin and hesperidin[J]Naunyn- Schmiedeberg.s Arch Phar2 macol, 2004,370:4521
[36]郑虎占,董泽宏,余靖.中药现代研究与应用[M],北京:学苑出版社,1998,第l版:2547-4638.
[37]徐理纳,徐德成,张向嘉,等.阿魏酸钠抗血小板聚集作用的机理研究2对TXA2 /PGI2平衡的影响[J]中国医学科学院学报, 1984,6(6):414.
[38]韩玲,陈可冀.川芎嗪对缺血再灌注心肌保护作用的研究进展[J]解放军药报2002,18(1)41-43.
[39]左保华,周志泳,杨金杰川芎嗪对再灌注心律失常的预防作用[J]九江医学,1995 10(4):196.
[1]陆再英,钟南山主编.内科学.第七版[M].北京:人民卫生出版社,2008:267.
[2]李宗军.冠心病危险因素及其控制.中国康复理论与实践,2002;8(10):596-597.
[3] Annual smoking-attributable mortality, years of potential life lost,and economic costs-United States, 1995-1999[J]. MMWRMorb Mortal WklyRep, 2002, 51: 300.
[4] He J, Vupputuri S, Allenk, eta.l Passive smoking and the risk of coronary heart disease: A meta-analysis of epide-miologic studies [J]. N Engl J Med,1999, 340: 920.
[5] Goldberg IJ.To drink ornot to drink? [J]. New Engl JMed, 2003,348: 163-164.
[6]朱明军,杜延海,余海滨,王永霞.冠心病中西医综合性康复的研究进展.中国民康医学杂志,2006,18(2):143-146.
[7] DomanskiM,MitchellG, PfefferM,et a.l Pulse pressure and cardio-vascular disease related mortality: follow-up study of the Multiple Risk Factor Intervention Trial (MRFIT) [J]. JAMA, 2002,287(20): 2677-2683.
[8]胡大一,马长生.心脏病学实践2004规范化治疗[M].北京:人民卫生出版社, 2004: 196.
[9] 2007中国慢性稳定性心绞痛诊断与治疗指南.中华心血管病杂志,2007, 35(3):195-206.
[10]阿依努尔,张明.冠心病在老年患者中的危险因素和治疗进展.中国社区医师,2007,16:3.
[11] LawMR, Wald N,j Wu T, et a.l Systematic underestimation of as-sociation between serum cholesterol concentration and ischaemic heart disease in observational studies: Datafrom the BUPA study, BMJ, 1994, 308: 363-366.
[12]王怡.冠心病的危险因素研究进展.天津中医药,2003;20(1):82-83.
[13] CuiK,CowleC,HarrisMl,etal .Diabetes and deelinein heartdisease motalityin US kdult[J] .JAmAssoe,1999,281:1291-1297.
[14]刘旭杰,张兴华.青年冠心病研究进展.心血管病学进展.2006,27(6):756-759.
[15]王桐英.冠心病病因研究进展[J].世界今日医学杂志,2004;5(1):50-52.
[16]李卫晖,李凌江.辩证的探讨精神应激与冠心病的关系[J].医学与哲学, 2006, 25(7): 26.
[17] Thadani U.Current medical management of chronic stable angina[J]. J CardiovascPharmacol ther,2004,9(suppll):11-29.
[18] Thadmai U The Pursuit of optimum outcomes instablangina[J].AmJCardiovase drugs,2003,3(suppl l):11-20.
[19]中华医学会心血管分会,中华心血管杂志编辑委员会,不稳定心绞痛诊断和治疗建议,中华心血管杂志2000,28(6);409-412.
[20] Freemantlen,Urdah1H,Eastaugh J,etal.What is the place of beta- bloekade in Patients who have xeperieneed a myoeardial information with preserved left ventroCular funetion? Evidence and (mis)inter Pretation .ProgCardiovaseD.S.2002,44(4):243-250.
[21]龙云,危玲,刘淑琦,等.程丑夫教授治疗冠心病经验.中国中医急症,2004, 13(7):450-451.
[22] Shepherd J,Cohbe SM,Fo rd I.Etad I Resention of coronary heart disease with pravsation in noon with hypercholeterolenda [J].NEngl J Med,1995. 333(2):1 301.
[23]吴庆昌,周丽.血脂康对心绞痛、心肌缺血总负荷和CRP的影响[J].中西医结合心脑血管病杂志,2004,2(9):499-501.
[24]樊永平.王绵之教授治疗冠心病的经验.贵阳中医学院学报,1995,17(1):38, 39,42.
[25]丁海琪,张玉,王玉英,等.活血化瘀类中药注射液治疗冠心病心绞痛的机制概述.云南中医中药杂志,2008,1,49-51.
[26] FoxKM.Effieacy of perindopril in reduetion of cardiovascular events Among Patients with stable coronary artery disease:random,double-bland,plaeebo-controlled, multieentretrial(the EUROPA study).Laeent,2003, 362(9386):782-788.
[27] Jyusufs,Sleight Pgue J,etal Effects of an angiotensin-converting- The Heart outeomes Prevention Evaluation Study Investigations.NEnglJMed, 2000,342(3):145-153.
[28]李海亮.尼可地尔治疗冠心病稳定型心绞痛72例临床分析[J].中国社区医师, 2008,(9)37.
[29]中华医学会心血管病学分会.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206.
[30] Zhu WL,Shan YD,Guo JX,et a1.Double-blind,muhicenter,active -eontroHed,randomized clinical trial to assess the safety and eficacy of orally administered nicorandil in patients with stable angina pectoris in China[J].Circ J,2007,71(6):826-833.
[31]马长生.冠心病介入治疗-技术与策略[M].2版.北京:人民卫生出版社,2005:4.
[32] OPROURKE R A. Optimal medical therapy is a proven option for chronic stable angina[J]. J Am Coll Cardiol,2008, 52 (11) : 90529071.
[33] SCH;MIGA, MEH ILL IJ , DEWAHA , et all America analysis of 17 randomized trials of a percutaneous coronary intervention-based strategy in patients with stable coronary artery disease [J] . J Am Coll Cardiol, 2008, 52 (11) : 89429041.
[34] SM ITH SCJR, FELDMAN TE, HIRSHFELD JWJR, et al1 ACC/AHA/SCA I 2005 guideline update forpercutaneous coronary intervention—summary article:areport of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (ACC/AHA /SCA I Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention) [J]. Circulation, 2006, 113 (1) : 15621751.
[35] DIXON SR, GRINESCL,OPNE ILL WWl The year in interventional cardiology [J].JAm Coll Cardiol,2008, 51 (24) : 2355223691.
[36] SILBER S, ALBERTSSON P, AV ILES F F, et all Guidelines for percutaneouscoronary interventions1 the Task Force for Percutaneous Coronary interventions of the European Society of Cardiology [J] .Eur Heart J,2005, 26 (8) : 80428471.
[37]韩学杰.沈绍功教授从痰论治冠心病经验.中国中医急症.2004,13(1):31-32.
[38]沈绍功.胸痹心痛诊治新识[J].中国中医药信息杂志,2001,8(5):1-2.
[39]武志平,任白实.十味温胆汤加减治疗胸痹心痛36例[J].四川中医,2002,20 (2):40.
[40]丁有钦,冼绍祥,吴伟,等.胸痹心泰胶囊治疗胸痹的临床研究[J].新中医1997 29(3):13-13.
[41]李福印.仲景括蒌薤白3方治疗胸痹心痛120例临床观察[J].国医论坛,2002, 17(13):6.
[42]戴嫣.活血温胆汤对冠心病患者血液流变学的影响[J].河南中医,2004;24(11): 31-32.
[43]韩丽华.宽胸丹治疗痰瘀阻滞型胸痹(冠心病心绞痛)临床观察[J].河南中医, 2005,25(l):35-36.
[44]杨惠民,韩丽蓓,盛彤,等.益气活血化痰法对老年高脂血症患者血管内皮功能及凝血系统的影响[J].中医杂志,2005(2):107-109.
[45]史海波.胸痹心痛中医治法研究[J] .时珍国医国药,2003,14(7):424.
[46]郑翠娥.茂蛙合剂治疗不稳定型心绞痛的临床观察与抗动脉粥样硬化机理的实验研究[A].山东中医药大学博士学位论文,2007;43.
[47]陈光新.董建华教授治疗胸痹的经验[J].湖北中医杂志,1988,(6):2-3.
[48]刘德桓,许真真,郭伟聪,等.冠心病心绞痛395例中医证型特点探讨[J].中医杂志,1995,36(10):617-618.
[49]耿素华.益气活血汤治疗气虚血疲型胸痹心痛疗效观察[J].河北中医,2004, 26(8):586-58.
[50]韩文宝.补阳还五汤治疗冠心病心绞痛60例疗效观察[J].实用中医内科杂志, 2007,21(5):48.
[51]单书健,陈子华.古今名医临证金鉴·胸痹心痛卷[M].北京:中国中医药出版社, 1999.368.
[52]张万义.从升补宗气论治老年冠心病心绞痛.湖北中医杂志,2003,25(5):27-28
[53]牛惠志,李晓明,陈响中,等.生脉胶囊治疗冠心病心绞痛临床疗效观察[J].中国中西医结合杂志,2000;20(4):290-291.
[54]沈琳.益气养阴法为主治疗胸痹体会[J].甘肃中医,2005,15(12):22.
[55]岑长所,符惠燕.通阳祛瘀方治疗冠心病心绞痛37例临床观察[J].新中医, 1999,31(12):18.
[56]吴以岭.从络病学说论治冠心病心绞痛[J],中国中医基础医学杂志,2001,7 (4):71.
[57]张轶英,金为群,蔡峥梅,等.通心络胶囊治疗胸痹(冠心病心绞痛)35例临床观察.上海中医药杂志,2005.39(2):12-13.
[58]李晓,杨军.胸痹心痛与营卫失调[J].山东中医药大学报,2000,24(2):88-89.
[59]张治祥,姜良铎.论祛风解表药在内伤杂证中的运用[J].陕西中医学院学报, 2000, 23 (2) : 16.
[60]罗再琼,黄淑芬,王明杰.论风药在冠心病心绞痛治疗中的地位与作用[J].中国中医急症, 2000,9(1):24.174.
[61]刘青云.中药药理学[M].北京:人民卫生出版社, 2002.118.
[62]范砚超,张国平,唐明,等.从毒论治动脉粥样硬化初探[J].山东中医杂志,2004, (23):261-263.
[63]陈萍,刘桂廷.刘桂廷从肺论治冠心病心绞痛的经验[J].陕西中医,2002,22(8): 720.
[64]李青,詹青,据坚.詹文涛教授辨证论治冠心病经验(三).中国中医急症,2004, 13(3):165-174.
[65]李洁,解品启.冠心病从脾胃论治.山西中医,1997,13(6):52 LI Jie,XIE Pin-qi.Treating coronary heart disease from spleen.Shanxi Journal of Traditional Chinese Medicine,1997,13(6):52.
[66]赵益业,林晓忠,张敏州.邓铁涛教授以心脾相关学说诊治冠心病经验介绍.新中医,2007,39(4):5.
[67]朱淑梅,张玉红.胸痹从脾胃论治,中医研究,200,14(5):33-34.
[68]方军.无症状性心肌缺血从脾论治体会[J] ,河南中医学院学报,2004,(3):43.
[69]周爱生.柴胡疏肝散加味治疗胸痹心痛的疗效观察[J].北京中医2004,4(23): 29.
[70]解军从肝论治冠心病心绞痛的临床观察吉林中医药2002,4(22):5.
[71]李青,詹青,据坚.詹文涛教授辨证论治冠心病经验(三).中国中医急症,2004, 13(3):165-174.
[72]沈丽.益气活血法治疗老年冠心病心绞痛62例[J].北京中医药大学学报,2000, 23:101.
[73]周中山.冠心病中医证型与血液流变学的相关性研究[J].湖南中医药导报2004 2(7):176.
[2]史载祥,等.现代中医心血管病学.北京:人民卫生出版社,2006.845-847.
[3]曹洪欣,张华敏.痰癖互结与冠心病机理辨识田.中医药学刊,2001,19(6): 544-545.
[4]王慧丽.补肾通心汤治疗老年冠心病心绞痛56例[J].吉林中医药,2003,2(5): 15.
[5]樊永平.王绵之教授治疗冠心病的经验.贵阳中医学院学报,1995,17(1):38 39,42.
[6]何应群.力可生颗粒剂治疗心绞痛62例疗效观察[J].国医论坛,2000,15(6), 26.
[7]赵永强.冠心病心绞痛脏腑辨证的临床意义[J] ,中西医结合心脑血管杂志, 2003,1(11):673.
[8]吕健,黄坚明,吴乐文分型治疗冠心病心绞痛190例临床观察四川中医2001 19(7):31-32.
[9]邓宝澄.自拟冠心通汤防治不稳定性心绞痛35例[J]辽宁中医杂志2002,29 (2):90.
[10]郭晓华,王宜芳.补心肾化痰瘀治疗冠心病初探[J].陕西中医,2006,27(11): 1388-1390.
[11]王洛芳.第四军医大学学报,1986;7(2):164.
[12]刘崇铭,于庆海,张利民.淫羊藿甙对心脏的影响[J]中草药,1982.13(9):30
[13]蒋淑君,许兰芝.淫羊藿总黄酮的药理作用研究进展[J].中国药学报,2004, 32(4):60.
[14]王英军,唐炜,孙英莲,等.淫羊藿总苷对麻醉开胸犬血流动力学的影响[J].中药药理与临床,2006,22(3、4):66.
[15]高其铭.西安医科大学学报,1992;13(3):223.
[16]胡娟,叶蕻芝,冯亚,等.3种闽产中药体外对大鼠血小板凝集的影响[J].福建中医学院学报,2007,17(6):23-26.
[17]付润芳,冯国清,于爽,等.复方美沙芬颗粒对枸橼酸引咳豚鼠镇咳及对蟾蜍食管纤毛运动的作用[J] .郑州大学学报(医学版),2007,42 ( 6 ):1159-1161.
[18]张贺鸣,韩联合,冯国清,等.巴戟天对培养乳鼠心肌细胞缺氧复氧损伤的防护作用.河南中医学院学报,2005;20(8):20-21.
[19]郑虎占,董泽宏,余靖.中药现代研究与应用[M],北京:学苑出版社,1998,第1版:2547-4638.
[20]田代华.实用中药辞典[M],北京:人民卫生出版社,2002,第1版:1533-1537.
[21]邹丽琐,等.桂枝蒸馏液对离体灌流鼠心缺血再灌注损伤的保护作用.北京中医药大学学报,1997,20(2):22.
[22]刘晓亮,董均树,杨秋平.复方丹参注射液对冠状动脉粥样硬化性心脏病患者的影响[M].中西医结合实用临床急救, 1998;5(l2):559.
[23]阴健主编.中药现代研究与临床应用[M].第一版.学苑出版社,1993,10.
[24] Liu AH, LinYH, YangM, et al. Developmentof the fingerprints for the quality of the roots of Salviamiltiorrhiza and its related preparations by HPLC-DAD and LC-MSN [J]. Journal of Chromatography, 2007,846:32-41.
[25]吴毓敏,梁振昌,吴虹.水蛭的抗血栓作用观察.山西医学院学报,1995;26(2):89.
[26]洪行球,沃兴德.半夏降血脂作用研究[J].浙江中医学报,1995,19( 2) :28.
[27]陈凌云,杨国祥.半夏药理研究概况.云南中医学院学报,1997;20(4):17-19.
[28]蒋文跃,杨宇.化痰药半夏、瓜蒌、浙贝母、石菖蒲对大鼠血液流变性的影响[J].中医杂志, 2002, 43( 3) : 215.
[29]马清钧,王淑玲.临床实用中药学,南昌:江西科学技术出版社,2001:717.
[30]雷载权主编.中药学,上海:上海科技出版社,1995,第1版:279.
[31] Adamn Alemayehn et al. Britsh journal of pharmalology 1994:111:205.
[32] C.C.Chou et Amrtican journal of phystology 1989:257:G709.
[33]彭洪福等:高原医学杂志,(l):29 .1985.
[34]李红芳,李丹明,瞿颂义,等枳实和陈皮对兔离体主动脉平滑肌条作用机理探讨[J]中成药, 2001,23(9):6581.
[35] Francisco Or allo, Ezequiel lvarez,H l ne Basar an, et all Comparative study of the vasorelaxant activity, super oxide-scavenging ability and cyclic nucleotide phos phodieste rase - inhibitory effects of hesper etin and hesperidin[J]Naunyn- Schmiedeberg.s Arch Phar2 macol, 2004,370:4521
[36]郑虎占,董泽宏,余靖.中药现代研究与应用[M],北京:学苑出版社,1998,第l版:2547-4638.
[37]徐理纳,徐德成,张向嘉,等.阿魏酸钠抗血小板聚集作用的机理研究2对TXA2 /PGI2平衡的影响[J]中国医学科学院学报, 1984,6(6):414.
[38]韩玲,陈可冀.川芎嗪对缺血再灌注心肌保护作用的研究进展[J]解放军药报2002,18(1)41-43.
[39]左保华,周志泳,杨金杰川芎嗪对再灌注心律失常的预防作用[J]九江医学,1995 10(4):196.
[1]陆再英,钟南山主编.内科学.第七版[M].北京:人民卫生出版社,2008:267.
[2]李宗军.冠心病危险因素及其控制.中国康复理论与实践,2002;8(10):596-597.
[3] Annual smoking-attributable mortality, years of potential life lost,and economic costs-United States, 1995-1999[J]. MMWRMorb Mortal WklyRep, 2002, 51: 300.
[4] He J, Vupputuri S, Allenk, eta.l Passive smoking and the risk of coronary heart disease: A meta-analysis of epide-miologic studies [J]. N Engl J Med,1999, 340: 920.
[5] Goldberg IJ.To drink ornot to drink? [J]. New Engl JMed, 2003,348: 163-164.
[6]朱明军,杜延海,余海滨,王永霞.冠心病中西医综合性康复的研究进展.中国民康医学杂志,2006,18(2):143-146.
[7] DomanskiM,MitchellG, PfefferM,et a.l Pulse pressure and cardio-vascular disease related mortality: follow-up study of the Multiple Risk Factor Intervention Trial (MRFIT) [J]. JAMA, 2002,287(20): 2677-2683.
[8]胡大一,马长生.心脏病学实践2004规范化治疗[M].北京:人民卫生出版社, 2004: 196.
[9] 2007中国慢性稳定性心绞痛诊断与治疗指南.中华心血管病杂志,2007, 35(3):195-206.
[10]阿依努尔,张明.冠心病在老年患者中的危险因素和治疗进展.中国社区医师,2007,16:3.
[11] LawMR, Wald N,j Wu T, et a.l Systematic underestimation of as-sociation between serum cholesterol concentration and ischaemic heart disease in observational studies: Datafrom the BUPA study, BMJ, 1994, 308: 363-366.
[12]王怡.冠心病的危险因素研究进展.天津中医药,2003;20(1):82-83.
[13] CuiK,CowleC,HarrisMl,etal .Diabetes and deelinein heartdisease motalityin US kdult[J] .JAmAssoe,1999,281:1291-1297.
[14]刘旭杰,张兴华.青年冠心病研究进展.心血管病学进展.2006,27(6):756-759.
[15]王桐英.冠心病病因研究进展[J].世界今日医学杂志,2004;5(1):50-52.
[16]李卫晖,李凌江.辩证的探讨精神应激与冠心病的关系[J].医学与哲学, 2006, 25(7): 26.
[17] Thadani U.Current medical management of chronic stable angina[J]. J CardiovascPharmacol ther,2004,9(suppll):11-29.
[18] Thadmai U The Pursuit of optimum outcomes instablangina[J].AmJCardiovase drugs,2003,3(suppl l):11-20.
[19]中华医学会心血管分会,中华心血管杂志编辑委员会,不稳定心绞痛诊断和治疗建议,中华心血管杂志2000,28(6);409-412.
[20] Freemantlen,Urdah1H,Eastaugh J,etal.What is the place of beta- bloekade in Patients who have xeperieneed a myoeardial information with preserved left ventroCular funetion? Evidence and (mis)inter Pretation .ProgCardiovaseD.S.2002,44(4):243-250.
[21]龙云,危玲,刘淑琦,等.程丑夫教授治疗冠心病经验.中国中医急症,2004, 13(7):450-451.
[22] Shepherd J,Cohbe SM,Fo rd I.Etad I Resention of coronary heart disease with pravsation in noon with hypercholeterolenda [J].NEngl J Med,1995. 333(2):1 301.
[23]吴庆昌,周丽.血脂康对心绞痛、心肌缺血总负荷和CRP的影响[J].中西医结合心脑血管病杂志,2004,2(9):499-501.
[24]樊永平.王绵之教授治疗冠心病的经验.贵阳中医学院学报,1995,17(1):38, 39,42.
[25]丁海琪,张玉,王玉英,等.活血化瘀类中药注射液治疗冠心病心绞痛的机制概述.云南中医中药杂志,2008,1,49-51.
[26] FoxKM.Effieacy of perindopril in reduetion of cardiovascular events Among Patients with stable coronary artery disease:random,double-bland,plaeebo-controlled, multieentretrial(the EUROPA study).Laeent,2003, 362(9386):782-788.
[27] Jyusufs,Sleight Pgue J,etal Effects of an angiotensin-converting- The Heart outeomes Prevention Evaluation Study Investigations.NEnglJMed, 2000,342(3):145-153.
[28]李海亮.尼可地尔治疗冠心病稳定型心绞痛72例临床分析[J].中国社区医师, 2008,(9)37.
[29]中华医学会心血管病学分会.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206.
[30] Zhu WL,Shan YD,Guo JX,et a1.Double-blind,muhicenter,active -eontroHed,randomized clinical trial to assess the safety and eficacy of orally administered nicorandil in patients with stable angina pectoris in China[J].Circ J,2007,71(6):826-833.
[31]马长生.冠心病介入治疗-技术与策略[M].2版.北京:人民卫生出版社,2005:4.
[32] OPROURKE R A. Optimal medical therapy is a proven option for chronic stable angina[J]. J Am Coll Cardiol,2008, 52 (11) : 90529071.
[33] SCH;MIGA, MEH ILL IJ , DEWAHA , et all America analysis of 17 randomized trials of a percutaneous coronary intervention-based strategy in patients with stable coronary artery disease [J] . J Am Coll Cardiol, 2008, 52 (11) : 89429041.
[34] SM ITH SCJR, FELDMAN TE, HIRSHFELD JWJR, et al1 ACC/AHA/SCA I 2005 guideline update forpercutaneous coronary intervention—summary article:areport of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (ACC/AHA /SCA I Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention) [J]. Circulation, 2006, 113 (1) : 15621751.
[35] DIXON SR, GRINESCL,OPNE ILL WWl The year in interventional cardiology [J].JAm Coll Cardiol,2008, 51 (24) : 2355223691.
[36] SILBER S, ALBERTSSON P, AV ILES F F, et all Guidelines for percutaneouscoronary interventions1 the Task Force for Percutaneous Coronary interventions of the European Society of Cardiology [J] .Eur Heart J,2005, 26 (8) : 80428471.
[37]韩学杰.沈绍功教授从痰论治冠心病经验.中国中医急症.2004,13(1):31-32.
[38]沈绍功.胸痹心痛诊治新识[J].中国中医药信息杂志,2001,8(5):1-2.
[39]武志平,任白实.十味温胆汤加减治疗胸痹心痛36例[J].四川中医,2002,20 (2):40.
[40]丁有钦,冼绍祥,吴伟,等.胸痹心泰胶囊治疗胸痹的临床研究[J].新中医1997 29(3):13-13.
[41]李福印.仲景括蒌薤白3方治疗胸痹心痛120例临床观察[J].国医论坛,2002, 17(13):6.
[42]戴嫣.活血温胆汤对冠心病患者血液流变学的影响[J].河南中医,2004;24(11): 31-32.
[43]韩丽华.宽胸丹治疗痰瘀阻滞型胸痹(冠心病心绞痛)临床观察[J].河南中医, 2005,25(l):35-36.
[44]杨惠民,韩丽蓓,盛彤,等.益气活血化痰法对老年高脂血症患者血管内皮功能及凝血系统的影响[J].中医杂志,2005(2):107-109.
[45]史海波.胸痹心痛中医治法研究[J] .时珍国医国药,2003,14(7):424.
[46]郑翠娥.茂蛙合剂治疗不稳定型心绞痛的临床观察与抗动脉粥样硬化机理的实验研究[A].山东中医药大学博士学位论文,2007;43.
[47]陈光新.董建华教授治疗胸痹的经验[J].湖北中医杂志,1988,(6):2-3.
[48]刘德桓,许真真,郭伟聪,等.冠心病心绞痛395例中医证型特点探讨[J].中医杂志,1995,36(10):617-618.
[49]耿素华.益气活血汤治疗气虚血疲型胸痹心痛疗效观察[J].河北中医,2004, 26(8):586-58.
[50]韩文宝.补阳还五汤治疗冠心病心绞痛60例疗效观察[J].实用中医内科杂志, 2007,21(5):48.
[51]单书健,陈子华.古今名医临证金鉴·胸痹心痛卷[M].北京:中国中医药出版社, 1999.368.
[52]张万义.从升补宗气论治老年冠心病心绞痛.湖北中医杂志,2003,25(5):27-28
[53]牛惠志,李晓明,陈响中,等.生脉胶囊治疗冠心病心绞痛临床疗效观察[J].中国中西医结合杂志,2000;20(4):290-291.
[54]沈琳.益气养阴法为主治疗胸痹体会[J].甘肃中医,2005,15(12):22.
[55]岑长所,符惠燕.通阳祛瘀方治疗冠心病心绞痛37例临床观察[J].新中医, 1999,31(12):18.
[56]吴以岭.从络病学说论治冠心病心绞痛[J],中国中医基础医学杂志,2001,7 (4):71.
[57]张轶英,金为群,蔡峥梅,等.通心络胶囊治疗胸痹(冠心病心绞痛)35例临床观察.上海中医药杂志,2005.39(2):12-13.
[58]李晓,杨军.胸痹心痛与营卫失调[J].山东中医药大学报,2000,24(2):88-89.
[59]张治祥,姜良铎.论祛风解表药在内伤杂证中的运用[J].陕西中医学院学报, 2000, 23 (2) : 16.
[60]罗再琼,黄淑芬,王明杰.论风药在冠心病心绞痛治疗中的地位与作用[J].中国中医急症, 2000,9(1):24.174.
[61]刘青云.中药药理学[M].北京:人民卫生出版社, 2002.118.
[62]范砚超,张国平,唐明,等.从毒论治动脉粥样硬化初探[J].山东中医杂志,2004, (23):261-263.
[63]陈萍,刘桂廷.刘桂廷从肺论治冠心病心绞痛的经验[J].陕西中医,2002,22(8): 720.
[64]李青,詹青,据坚.詹文涛教授辨证论治冠心病经验(三).中国中医急症,2004, 13(3):165-174.
[65]李洁,解品启.冠心病从脾胃论治.山西中医,1997,13(6):52 LI Jie,XIE Pin-qi.Treating coronary heart disease from spleen.Shanxi Journal of Traditional Chinese Medicine,1997,13(6):52.
[66]赵益业,林晓忠,张敏州.邓铁涛教授以心脾相关学说诊治冠心病经验介绍.新中医,2007,39(4):5.
[67]朱淑梅,张玉红.胸痹从脾胃论治,中医研究,200,14(5):33-34.
[68]方军.无症状性心肌缺血从脾论治体会[J] ,河南中医学院学报,2004,(3):43.
[69]周爱生.柴胡疏肝散加味治疗胸痹心痛的疗效观察[J].北京中医2004,4(23): 29.
[70]解军从肝论治冠心病心绞痛的临床观察吉林中医药2002,4(22):5.
[71]李青,詹青,据坚.詹文涛教授辨证论治冠心病经验(三).中国中医急症,2004, 13(3):165-174.
[72]沈丽.益气活血法治疗老年冠心病心绞痛62例[J].北京中医药大学学报,2000, 23:101.
[73]周中山.冠心病中医证型与血液流变学的相关性研究[J].湖南中医药导报2004 2(7):176.